USP10
Basic information
Region (hg38): 16:84699986-84779922
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the USP10 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 59 | 62 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 59 | 3 | 0 |
Variants in USP10
This is a list of pathogenic ClinVar variants found in the USP10 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-84700097-C-T | not specified | Uncertain significance (Oct 12, 2022) | ||
16-84700106-C-T | not specified | Uncertain significance (Dec 22, 2023) | ||
16-84733469-A-G | not specified | Uncertain significance (Apr 17, 2023) | ||
16-84733476-C-A | not specified | Uncertain significance (Oct 03, 2022) | ||
16-84733484-C-T | not specified | Uncertain significance (Dec 06, 2022) | ||
16-84744646-G-C | not specified | Uncertain significance (Apr 26, 2024) | ||
16-84744657-T-A | not specified | Uncertain significance (Oct 31, 2022) | ||
16-84744681-C-A | not specified | Uncertain significance (Sep 15, 2021) | ||
16-84744699-G-C | not specified | Uncertain significance (Jan 19, 2024) | ||
16-84744726-C-T | not specified | Uncertain significance (Aug 16, 2021) | ||
16-84744788-G-T | not specified | Uncertain significance (Oct 22, 2021) | ||
16-84744795-C-G | not specified | Uncertain significance (Dec 14, 2022) | ||
16-84744801-A-G | not specified | Uncertain significance (Dec 19, 2022) | ||
16-84744804-C-T | not specified | Likely benign (Dec 21, 2023) | ||
16-84744813-G-T | not specified | Uncertain significance (May 05, 2023) | ||
16-84744848-G-A | not specified | Uncertain significance (Feb 10, 2023) | ||
16-84744869-G-A | not specified | Uncertain significance (Feb 23, 2023) | ||
16-84744927-G-A | not specified | Uncertain significance (Sep 15, 2021) | ||
16-84744954-G-A | not specified | Uncertain significance (Aug 01, 2022) | ||
16-84744986-G-C | not specified | Uncertain significance (Jun 24, 2022) | ||
16-84745002-A-C | not specified | Uncertain significance (Mar 20, 2024) | ||
16-84745046-G-C | not specified | Uncertain significance (Nov 30, 2021) | ||
16-84745095-C-A | not specified | Uncertain significance (Jul 19, 2023) | ||
16-84745139-A-G | not specified | Uncertain significance (Dec 04, 2023) | ||
16-84745158-G-T | not specified | Uncertain significance (Nov 09, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
USP10 | protein_coding | protein_coding | ENST00000219473 | 14 | 79945 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.994 | 0.00589 | 124298 | 0 | 345 | 124643 | 0.00138 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.674 | 494 | 454 | 1.09 | 0.0000256 | 5158 |
Missense in Polyphen | 116 | 162.09 | 0.71565 | 1942 | ||
Synonymous | -2.29 | 227 | 187 | 1.21 | 0.0000121 | 1611 |
Loss of Function | 4.90 | 5 | 37.3 | 0.134 | 0.00000205 | 434 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000374 | 0.000352 |
Ashkenazi Jewish | 0.00200 | 0.00189 |
East Asian | 0.0175 | 0.0168 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000120 | 0.0000973 |
Middle Eastern | 0.0175 | 0.0168 |
South Asian | 0.000249 | 0.000229 |
Other | 0.000352 | 0.000330 |
dbNSFP
Source:
- Function
- FUNCTION: Hydrolase that can remove conjugated ubiquitin from target proteins such as p53/TP53, BECN1, SNX3 and CFTR. Acts as an essential regulator of p53/TP53 stability: in unstressed cells, specifically deubiquitinates p53/TP53 in the cytoplasm, leading to counteract MDM2 action and stabilize p53/TP53. Following DNA damage, translocates to the nucleus and deubiquitinates p53/TP53, leading to regulate the p53/TP53-dependent DNA damage response. Component of a regulatory loop that controls autophagy and p53/TP53 levels: mediates deubiquitination of BECN1, a key regulator of autophagy, leading to stabilize the PIK3C3/VPS34- containing complexes. In turn, PIK3C3/VPS34-containing complexes regulate USP10 stability, suggesting the existence of a regulatory system by which PIK3C3/VPS34-containing complexes regulate p53/TP53 protein levels via USP10 and USP13. Does not deubiquitinate MDM2. Deubiquitinates CFTR in early endosomes, enhancing its endocytic recycling. Involved in a TANK-dependent negative feedback response to attenuate NF-kappaB activation via deubiquitinating IKBKG or TRAF6 in response to interleukin-1-beta (IL1B) stimulation or upon DNA damage (PubMed:25861989). Deubiquitinates TBX21 leading to its stabilization (PubMed:24845384). {ECO:0000269|PubMed:11439350, ECO:0000269|PubMed:18632802, ECO:0000269|PubMed:19398555, ECO:0000269|PubMed:20096447, ECO:0000269|PubMed:21962518, ECO:0000269|PubMed:24845384, ECO:0000269|PubMed:25861989}.;
- Pathway
- DNA Repair;Post-translational protein modification;Metabolism of proteins;Ub-specific processing proteases;Deubiquitination;Termination of translesion DNA synthesis;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;DNA Damage Bypass
(Consensus)
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.523
- rvis_EVS
- -0.24
- rvis_percentile_EVS
- 36.31
Haploinsufficiency Scores
- pHI
- 0.697
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.553
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.501
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Usp10
- Phenotype
- cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- usp10
- Affected structure
- post-vent region
- Phenotype tag
- abnormal
- Phenotype quality
- curled
Gene ontology
- Biological process
- ubiquitin-dependent protein catabolic process;autophagy;cellular response to DNA damage stimulus;regulation of autophagy;protein deubiquitination;translesion synthesis;DNA damage response, signal transduction by p53 class mediator;negative regulation of I-kappaB kinase/NF-kappaB signaling;cellular response to interleukin-1
- Cellular component
- nucleus;nucleoplasm;cytoplasm;early endosome;cytosol;protein-containing complex
- Molecular function
- p53 binding;RNA binding;cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;protein binding;thiol-dependent ubiquitinyl hydrolase activity;ion channel binding